| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Wednesday’s Close |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $23.43 | $23.86B | N/A |
J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos
http://www.zacks.com/stock/news/575752/jj-jnj-recalls-baby-powder-batch-as-fda-finds-asbestos?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-575752
Oct 21, 2019 - J&J (JNJ) voluntarily recalls one lot of its baby powders, which is the subject of numerous lawsuits claiming that its talc-based products contain asbestos that causes cancer.
0
TEVA: Gabelli & Co ups to Buy
https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20191017082319
Oct 17, 2019 - Gabelli & Co issues rating change for TEVA
0
Five companies said to be in talks over $22 billion opioid settlement
https://www.cnbc.com/2019/10/16/five-companies-said-to-be-in-talks-over-22-billion-opioid-settlement.html
Oct 16, 2019 - Three major drug distributors – McKesson, AmerisourceBergen and Cardinal Health – are in discussions to pay $18 billion, while drugmaker Johnson & Johnson has offered $4 billion.
0
J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View
http://www.zacks.com/stock/news/565810/jj-jnj-beats-on-q3-earnings-as-sales-rise-ups-2019-view?cid=CS-ZC-FT-analyst_blog|earnings_article-565810
Oct 15, 2019 - J&J (JNJ) comes up with encouraging third-quarter 2019 results.
0
Lilly Gets FDA Approval for New Oral Tablets for Migraine
http://www.zacks.com/stock/news/563662/lilly-gets-fda-approval-for-new-oral-tablets-for-migraine?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-563662
Oct 14, 2019 - Eli Lilly (LLY) gets FDA approval for lasmiditan oral tablets to treat acute migraine in adults.
0
Jim Cramer Shares His Thoughts On Teva Pharmaceutical, MGM Resorts And More
http://feeds.benzinga.com/~r/benzinga/~3/ggRLhSSoZus/jim-cramer-shares-his-thoughts-on-teva-pharmaceutical-mgm-resorts-and-more
Oct 12, 2019 -
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't like Teva Pharmaceutical Industries Ltd (NYSE: TEVA). He would sell the stock.
0
Cramer's lightning round: MGM's gambling and sports plans are 'spectacular'
https://www.cnbc.com/2019/10/11/cramer-lightning-round-mgm-has-spectacular-gambling-sports-plans.html
Oct 11, 2019 - Jim Cramer takes calls and opines on viewer stock picks of the day in rapid speed.
0
Teva sells logistics center for $127M
https://seekingalpha.com/news/3505082-teva-sells-logistics-center-127m?source=feed_news_all
Oct 10, 2019 - Advancing its turnaround plan that includes the divestment of a range of assets, Teva Pharmaceutical Industries (TEVA +1.5%) has agreed to sell its Shoham-based 50,000 sq. ft. logistics center to real
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know
http://www.zacks.com/stock/news/553574/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-553574
Oct 07, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $6.98 in the latest trading session, marking a +0.14% move from the prior day.
0
AstraZeneca's Fasenra Gets FDA Nod for Self-Administration
http://www.zacks.com/stock/news/552912/astrazenecas-fasenra-gets-fda-nod-for-self-administration?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-552912
Oct 07, 2019 - The FDA approval of the self-administration option and auto-injector of AstraZeneca's (AZN) Fasenra is supported by data from the phase III GRECO study and the phase I AMES study
0